Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice

Clinical and Experimental Metastasis

Volumn 17, Issue 1, 1999, Pages 35-40

  Iigo, Masaaki ^a   Kuhara, Tetsuya ^a   Ushida, Yoshihiko ^a   Sekine, Kazunori ^a   Moore, Malcolm A ^a   Tsuda, Hiroyuki ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Antimetastasis; AsialoGM1+ cells; Colon carcinoma 26; Lactoferrin; Lung metastasis

Indexed keywords

CD8 ANTIGEN; COMPLEMENT; GANGLIOSIDE ANTIBODY; GANGLIOTETRAOSYLCERAMIDE; IRON BINDING PROTEIN; LACTOFERRICIN; LACTOFERRIN; MONOCLONAL ANTIBODY; PROTEIN HYDROLYSATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; COCULTURE; COLON CARCINOMA; CONTROLLED STUDY; DOSE RESPONSE; LEUKOCYTE; LUNG METASTASIS; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; NUDE MOUSE; ORAL DRUG ADMINISTRATION; SUBCUTANEOUS TISSUE TUMOR;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; ANTINEOPLASTIC AGENTS; CATTLE; CELL DIVISION; CELL SURVIVAL; COLONIC NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; HYDROLYSIS; LACTOFERRIN; LEUKOCYTES; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE;

EID: 0033028757     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Arnold RR, Cole MF, McGhee JR. A bactericidal effect for human lactoferrin. Science 1997; 197: 263-5.
2. Aisen P, Listowsky I. Iron transport and storage proteins. Ann Rev Biochem 1980; 49: 357-93.
3. Shau H, Kim A, Golub H. Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin. J Leukocyte Biol 1992; 51: 343-9.
4. Horwitz DA, Bakke AC, Abo W, Nishiya K. Monocyte and NK cell cytotoxic activity in human adherent cell preparations: discriminating effects of interferon and lactoferrin. J Immunol 1984; 132: 2370-4.
5. Gahr M, Speer CP, Damerau B, Sawatzki G. Influence of lactoferrin on the function of human polymorphonuclear leukocytes and monocytes. J Leukocyte Biol 1991; 49: 427-33.
6. Sawatzki G, Rich IN. Lactoferrin stimulates colony stimulating factor production in vitro and in vivo. Blood Cells 1989; 371-85.
7. Gentile P, Boxmeyer HE. Suppression of mouse myeclopoiesis by administration of human lactoferrin in vivo and the comparative action of human transferrin. Blood 1983; 61: 982-93.
8. Sekine K, Watanabe E, Nakamura J et al. Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats. Jpn J Cancer Res 1997; 88: 523-6.
9. Sekine K, Ushida Y, Kuhara T et al. Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administrated bovine lactoferrin concomitantly with azoxymethane. Cancer Lett 1997; 121: 211-6.
10. Bezault J, Bhimani R, Wiprovnick J, Furmanski P, Human lactoferrin inhibits growth of solid tumor and development of experimental metastases in mice. Cancer Res 1994; 54: 2310-2.
11. Yoo Y-C, Watanabe S, Watanabe R et al. Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice. Jpn J Cancer Res 1997; 88: 184-90.
12. Iigo M, Tsuda H, Moriyama M. Enhanced therapeutic effects of antitumour agents against growth and metastasis of colon carcinoma 26 when given in combination with interferon and interleukin-2. Clin Exp Metastasis 1994; 12: 368-74.
13. Iigo M, Nishikata K, Nakajima Y, Araki E. Effects of antitumour agents on subcutaneous implants and hepatic metastases of colon carcinoma 26 in mice. Jpn J Cancer Res 1992; 83: 397-401.
14. Iigo M, Shimamura M, Sagawa K, Tsuda H. Characteristics of the inhibitory effect of mitoxantrone and pirarubicin on lung metastases of colon carcinoma 26. Jpn J Cancer Res 1995; 86: 867-72.
15. Tomita M, Bellamy W, Takase M et al. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J Dairy Sci 1992; 4137-42.
16. Moriyama M, Harada K, Kawasaki H et al. Characterization of extrathymic T cells induced by recombinant murine interferon-β in the peritoneal cavity of nude mice. J Interferon Cytokine Res 1995; 15: 925-31.
17. Glazer RI, Lloyd LS. Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture. Mol Pharmacol 1982; 21: 468-73.
18. Riviere Y, Hovanessian AG. Antitumoral action of interferon and poly(A)poly(U) on Hela xenografts in the nude mouse. Ann Immunol 1984; 135: 333-43.
19. Piscatelli JJ, Cohen SA, Berenson CS, Lance P. Determinants of differential liver-colonizing potential of variants of the MCA-38 murine colon cancer cell line. Clin Exp Metastasis 1995; 13: 141-50.
20. Cavacini LA, Gites-Komar J, Kennel M. Quinn A. Effect of immuno-suppressive therapy on cytolytic activity of immuno deficient mice: implications for xenogeneic transplantation. Cell Immunol 1992; 144: 296-310.
21. Migliore-Samour D, Floch'h F, Jolle's P. Biologically active casein peptides implicated in immuno-modulation. J Dairy Res 1989; 56: 357-62.
22. Shinoda I, Takase M, Fukuwatari Y et al. Effects of lactoferrin and lactoferricin on the release of interleukin 8 from human polymorphonuclear leukocytes. Biosci Biotech Biochem 1996; 60: 521-3.
23. Arenberg DA, Kunkel SL, Polverini PJ et al. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest 1996; 97: 2792-802.
24. Singh RK, Gutman M, Radinsky R et al. Expression of interleukin-8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res 1994; 54: 3242-7.
25. Ueda T, Shimada E, Urakawa T. Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis. J Gastroenterol 1994; 29: 423-9.